Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Buys $68,780.00 in Stock

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Paul J. Isaac purchased 38,000 shares of the business’s stock in a transaction on Monday, March 10th. The stock was purchased at an average cost of $1.81 per share, with a total value of $68,780.00. Following the acquisition, the director now owns 87,299 shares in the company, valued at approximately $158,011.19. This represents a 77.08 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Stereotaxis Stock Performance

Stereotaxis stock opened at $1.79 on Wednesday. The firm has a 50 day moving average price of $2.25. The firm has a market cap of $151.67 million, a PE ratio of -6.39 and a beta of 1.54. Stereotaxis, Inc. has a 12 month low of $1.66 and a 12 month high of $3.29.

Hedge Funds Weigh In On Stereotaxis

A number of hedge funds have recently modified their holdings of the stock. State of Wyoming raised its holdings in shares of Stereotaxis by 14.8% in the 4th quarter. State of Wyoming now owns 536,698 shares of the company’s stock worth $1,224,000 after buying an additional 69,259 shares in the last quarter. ProShare Advisors LLC grew its position in Stereotaxis by 53.6% during the 4th quarter. ProShare Advisors LLC now owns 15,913 shares of the company’s stock worth $36,000 after acquiring an additional 5,556 shares during the last quarter. Lagoda Investment Management L.P. grew its position in Stereotaxis by 7.7% during the 4th quarter. Lagoda Investment Management L.P. now owns 4,126,135 shares of the company’s stock worth $9,408,000 after acquiring an additional 295,700 shares during the last quarter. Bank of America Corp DE grew its position in Stereotaxis by 79.7% during the 4th quarter. Bank of America Corp DE now owns 81,427 shares of the company’s stock worth $186,000 after acquiring an additional 36,123 shares during the last quarter. Finally, Northern Trust Corp grew its position in Stereotaxis by 3.6% during the 4th quarter. Northern Trust Corp now owns 480,577 shares of the company’s stock worth $1,096,000 after acquiring an additional 16,571 shares during the last quarter. 45.35% of the stock is owned by institutional investors and hedge funds.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.